Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pentabiol is a Spanish biotechnology company specialized in the research, development, and production of postbiotics designed to improve animal health and nutrition. Based in Navarre, the company utilizes a proprietary fermentation platform to create products that stabilize the intestinal microbiota and enhance the immune response of livestock and pets. Its flagship product lines, such as ProPental, are used in swine, poultry, and ruminant farming to improve productivity and serve as a natural alternative to prophylactic antibiotic use. Pentabiol controls the entire production cycle, from the selection of specific microbial strains to industrial-scale manufacturing at its dedicated facility. The company maintains an active R&D strategy through collaborations with academic institutions to expand the application of postbiotic technology in the agrifood sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pentabiol.